Consonance Capital Management as of March 31, 2018
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 26 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Radius Health | 9.5 | $104M | 2.9M | 35.94 | |
| Spectrum Pharmaceuticals | 9.1 | $100M | 6.2M | 16.09 | |
| Corcept Therapeutics Incorporated (CORT) | 7.8 | $85M | 5.2M | 16.45 | |
| Retrophin | 7.5 | $83M | 3.7M | 22.36 | |
| Pacira Pharmaceuticals (PCRX) | 7.5 | $82M | 2.6M | 31.15 | |
| United Therapeutics Corporation (UTHR) | 5.8 | $64M | 567k | 112.36 | |
| NuVasive | 5.2 | $57M | 1.1M | 52.21 | |
| Urogen Pharma (URGN) | 5.2 | $57M | 1.1M | 49.69 | |
| Iovance Biotherapeutics (IOVA) | 5.0 | $54M | 3.2M | 16.90 | |
| Amarin Corporation (AMRN) | 4.9 | $53M | 18M | 3.01 | |
| Vanda Pharmaceuticals (VNDA) | 4.7 | $52M | 3.1M | 16.85 | |
| D Stemline Therapeutics | 3.6 | $40M | 2.6M | 15.30 | |
| Dynavax Technologies (DVAX) | 3.0 | $33M | 1.7M | 19.85 | |
| Vericel (VCEL) | 2.8 | $31M | 3.1M | 9.95 | |
| Gw Pharmaceuticals Plc ads | 2.8 | $31M | 273k | 112.67 | |
| Oxford Immunotec Global | 2.7 | $29M | 2.3M | 12.45 | |
| Pacific Biosciences of California (PACB) | 2.4 | $26M | 13M | 2.05 | |
| Savara (SVRA) | 2.3 | $25M | 2.7M | 9.20 | |
| Uniqure Nv (QURE) | 2.2 | $25M | 1.0M | 23.50 | |
| Adma Biologics (ADMA) | 1.4 | $15M | 3.3M | 4.60 | |
| Catalyst Pharmaceutical Partners (CPRX) | 1.1 | $12M | 5.0M | 2.39 | |
| Cardiovascular Systems | 0.9 | $9.8M | 446k | 21.93 | |
| Biosante Pharmaceuticals (ANIP) | 0.8 | $8.3M | 143k | 58.22 | |
| Ra Pharmaceuticals | 0.7 | $7.7M | 1.5M | 5.31 | |
| Corindus Vascular Robotics I | 0.6 | $6.3M | 4.6M | 1.37 | |
| Flexion Therapeutics | 0.4 | $4.6M | 207k | 22.41 |
